rs727505232
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_000260.4(MYO7A):c.5169-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,547,596 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000260.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.5169-5G>A | splice_region_variant, intron_variant | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.5169-5G>A | splice_region_variant, intron_variant | 1 | NM_000260.4 | ENSP00000386331.3 | ||||
MYO7A | ENST00000458637.6 | c.5055-5G>A | splice_region_variant, intron_variant | 1 | ENSP00000392185.2 | |||||
MYO7A | ENST00000409619.6 | c.5022-5G>A | splice_region_variant, intron_variant | 1 | ENSP00000386635.2 | |||||
MYO7A | ENST00000458169.2 | c.2595-5G>A | splice_region_variant, intron_variant | 1 | ENSP00000417017.2 | |||||
MYO7A | ENST00000670577.1 | n.3009-5G>A | splice_region_variant, intron_variant | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000344 AC: 51AN: 148422Hom.: 1 AF XY: 0.000442 AC XY: 35AN XY: 79220
GnomAD4 exome AF: 0.000128 AC: 178AN: 1395404Hom.: 2 Cov.: 31 AF XY: 0.000182 AC XY: 125AN XY: 688318
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 11, 2022 | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 09, 2014 | The 5169-5G>T variant in MYO7A has not been previously reported in individuals w ith hearing loss. Data from large population studies is insufficient to assess t he frequency of this variant. This variant is located in the 3' splice region. C omputational tools suggest an impact to splicing; however, this information is n ot predictive enough to determine pathogenicity. In summary, the clinical signif icance of the 5169-5G>A variant is uncertain. - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 17, 2020 | - - |
MYO7A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 16, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at